Novo Nordisk A/S (NVO) Social Stream



Novo Nordisk A/S (NVO): $105.38

2.83 (+2.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NOVO NORDISK A S (NVO) Price Targets From Analysts

Use the tables below to see what analysts covering NOVO NORDISK A S think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $118.8 $115 $116.9 $102.55 13.99%
2022-02-09 4 $118.8 $115 $116.9 $102.55 13.99%
2022-04-19 4 $132.6 $115 $123.8 $102.55 20.72%
2022-04-25 4 $130 $118.8 $124.4 $102.55 21.31%
2022-05-12 4 $134.6 $130 $132.3 $102.55 29.01%
2022-06-16 5 $134.6 $130 $132.3 $102.55 29.01%
2022-08-05 7 $134.6 $130 $132.3 $102.55 29.01%
2022-09-17 8 $134.6 $130 $132.3 $102.55 29.01%

The Trend in the Analyst Price Target


NVO's average price target has moved up $66.02 over the prior 28 months.

Over the past 45 weeks, NVO's average upside potential has been 18.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-04 4 118.8 115 116.9 115.85 0.91%
2022-04-11 4 132.6 115 123.8 120.95 2.36%
2022-04-29 4 134.6 130 132.3 114.00 16.05%
2022-05-12 4 134.6 130 132.3 104.35 26.78%
2022-06-29 7 134.6 130 132.3 110.08 20.19%

NVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.13 5 0 1 1 1 8

The Trend in the Broker Recommendations


NVO's average broker recommendation rating improved by 0.13 over the prior 153 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, NOVO NORDISK A S's variance in analysts' estimates is lower than 50.48% of them.
  • NVO has a higher number of analysts covering the stock than 14.93% of stocks in the mega market cap category.
  • NOVO NORDISK A S's average analyst price target is greater than 625.26% of Pharmaceutical Products stocks.
  • NVO has a greater upside potential (average analyst target price relative to current price) than 93.48% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, MRK, LLY, and JNJ are the three stocks most similar to NOVO NORDISK A S regarding the price target and analyst recommendation information presented here.

What is the outlook for NVO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5844 seconds.